Latest Articles
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - PR Newswire
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids PR Newswire
Published: May 7, 2025, noon
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids - 스페셜타임스
TiumBio and Daewon Pharmaceutical Successfully Complete Phase 2 Clinical Trial of 'Merigolix (TU2670/DW4902)' for Uterine Fibroids 스페셜타임스
Published: May 7, 2025, noon
Drug Discovery Science Articles | Page 83 - Technology Networks
Drug Discovery Science Articles | Page 83 Technology Networks
Published: May 7, 2025, 11:32 a.m.
Linzagolix approved as second at-home treatment option for endometriosis - Pulse Today
Linzagolix approved as second at-home treatment option for endometriosis Pulse Today
Published: May 7, 2025, 11:25 a.m.
Aspira Successfully Completes Application to the OTCQB - ACCESS Newswire
Aspira Successfully Completes Application to the OTCQB ACCESS Newswire
Published: May 7, 2025, 11:04 a.m.
EndoFound and Cold Spring Harbor Laboratory Launch $20M Endometriosis Research Center - Femtech Insider
EndoFound and Cold Spring Harbor Laboratory Launch $20M Endometriosis Research Center Femtech Insider
Published: May 7, 2025, 10:29 a.m.
A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images - Nature
A Radiomic-based model to predict the depth of myometrial invasion in endometrial cancer on ultrasound images Nature
Published: May 7, 2025, 10:05 a.m.
BBC Breakfast's Jon Kay says 'let's not start any rumours' as he congratulates co-star on baby news - Manchester Evening News
BBC Breakfast's Jon Kay says 'let's not start any rumours' as he congratulates co-star on baby news Manchester Evening News
Published: May 7, 2025, 9:53 a.m.
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial - koreabiomed.com
Daewon Pharm’s uterine fibroid drug meets primary endpoint in P2 trial koreabiomed.com
Published: May 7, 2025, 6:51 a.m.
New daily endometriosis pill approved for NHS use - Open Access Government
New daily endometriosis pill approved for NHS use Open Access Government
Published: May 7, 2025, 5:32 a.m.
Link copied to clipboard!